The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: an experimental study in myringosclerosis.
Myringosclerosis (MyS) is a common sequela of acute and chronic otitis media and ventilation tube treatment of serous otitis media. We aimed to study the effect of topical administration of N -acetylcysteine (NAC) on MyS by assessment of otomicroscopic evaluation, lipid peroxidation and nitric oxide (NO) (nitrite/nitrate) levels in experimental myringotomized rat tympanic membrane. Thirty adult rats were used and the upper posterior quadrant of the tympanic membranes of rats was myringotomized. Thereafter, they were divided into four groups. Group I received no treatment, group II was treated with saline, groups III and IV were treated with topical NAC (0.1 ml of 6 and 12 mg ml(-1), respectively). The levels of nitrite/nitrate and malondialdehyde (MDA) were measured in serum samples. In the otomicroscopic evaluation, non-treated and saline treated ears (controls) showed extensive occurrence of myringosclerotic plaques. Groups III and IV showed fewer occurrences of sclerotic plaques. There was no significant difference between groups III and IV regarding the development of MyS. The development of myringosclerotic lesion was found to be significantly different between NAC treated groups (III and IV) and the control groups (I and II). The levels of nitrite/nitrate of both groups III and IV were significantly lower than the control groups. The levels of MDA of these groups were also significantly lower than the control group. The relationship between groups III and IV was not statistically significant for the levels of nitrite/nitrate and MDA. We conclude that the topical treatment of NAC reduces the levels of MDA and NO products in rats. These results suggest that topical NAC application may be useful for the prevention of MyS.
Ozcan
Cengiz
C
Department of Otorhinolaryngology, Mersin University, School of Medicine, Mersin, Turkey. cengizozcan@hotmail.com
Polat
Gürbüz
G
Görür
Kemal
K
Talas
Derya Umit
DU
Bağdatoğlu
Ozlen
O
Cinel
Ismail
I
D000111:Acetylcysteine / Q000494:pharmacology*; D000287:Administration, Topical; D000818:Animals; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008853:Microscopy / Q000379:methods; D009569:Nitric Oxide / Q000378:metabolism; D010033:Otitis Media / Q000209:etiology / Q000378:metabolism; D010040:Otosclerosis / Q000209:etiology / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014432:Tympanic Membrane / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018058:Tympanic Membrane Perforation / Q000150:complications*
D009569:Nitric Oxide; D008315:Malondialdehyde; D010100:Oxygen; D000111:Acetylcysteine